Arbutamine

Drug Profile

Arbutamine

Alternative Names: Genesa; GP 21213

Latest Information Update: 14 Jul 2010

Price : $50

At a glance

  • Originator SICOR
  • Class Cardiotonics; Catecholamines; Small molecules
  • Mechanism of Action Alpha 1 adrenergic receptor agonists; Beta-adrenergic receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Marketed Coronary artery disease

Most Recent Events

  • 14 Jul 2010 No development reported - Preregistration for Coronary artery disease in Switzerland (IV)
  • 14 Jul 2010 No development reported - Preregistration for Coronary artery disease in Canada (IV)
  • 28 Jan 2004 SICOR has been acquired by Teva Pharmaceutical Industries
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top